![]() |
![]() |
,4-dimethyl-1,3-dioxo-2(1h)-isoquinolinyl)ethyl)- 1-Cyclohexyl-3-[4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxo-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]benzenesulfonyl]urea 1-Cyclohexyl-3-[4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxoisoquinolin-2-yl)ethyl]phenyl]sulfonylurea AR-DF 26 ARDF 26SE ardf26 ardf26se Beglynor Benzenesulfonamide, N-[(cyclohexylamino)carbonyl]-4-[2-(3,4-dihydro-7-methoxy-4,4-dimethyl-1,3-dioxo-2(1H)-isoquinolinyl)ethyl]- benzenesulfonamide,n-((cyclohexylamino)carbonyl)-4-(2-(3,4-dihydro-7-methoxy-4 Gliquidone Tablets Glurenorm N-[(Cyclohexylamino)carbonyl]-4-[2-(3,4-dihydro-7-methoxy-4,4-dimethyl-1,3-dioxo-2(1H)-isoquinolinyl)ethyl]benzenesulfonamide TangShenPing TangShiPing ZINC 01482077 ZINC 1482077
Low toxicity by ingestion. Experimental reproductive effects. When heated to decomposition it emits toxic vapors of NOx and SOx.
Safety information of Gliquidone (33342-05-1):
RTECS DB1584250
1. |
orl-mus LD50:>15 g/kg |
USXXAM United States Patent Document. (Commissioner of Patents and Trademarks, Washington, DC 20231) #3708486 . |
Not classified.
Pictogram(s) | No symbol. |
---|---|
Signal word | No signal word. |
Hazard statement(s) | none |
Precautionary statement(s) | |
Prevention | none |
Response | none |
Storage | none |
Disposal | none |
none